Receptor Tyrosine Kinase Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Receptor Tyrosine Kinase stocks.

Receptor Tyrosine Kinase Stocks Recent News

Date Stock Title
Nov 1 BPMC High Growth Tech Stocks to Watch in November 2024
Nov 1 BPMC Blueprint Medicines Third Quarter 2024 Earnings: EPS Beats Expectations
Nov 1 EXEL Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
Oct 31 EXEL Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine
Oct 31 BPMC BPMC Beats on Q3 Earnings and Sales, Raises '24 View, Stock Up
Oct 31 EXEL Exelixis price target raised to $36 from $33 at Piper Sandler
Oct 31 BPMC Blueprint Medicines Corp (BPMC) Q3 2024 Earnings Call Highlights: Record AYVAKIT Revenue and ...
Oct 31 BPMC Q3 2024 Blueprint Medicines Corp Earnings Call
Oct 30 BPMC Blueprint Medicines Corporation (BPMC) Q3 2024 Earnings Call Transcript
Oct 30 EXEL Q3 2024 Exelixis Inc Earnings Call
Oct 30 EXEL Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook
Oct 30 BPMC Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
Oct 30 BPMC Blueprint Medicines: Q3 Earnings Snapshot
Oct 30 BPMC Blueprint Medicines beats Q3 top and bottom-line estimates
Oct 30 BPMC Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Oct 30 EXEL Exelixis Inc (EXEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Oct 30 EXEL Exelixis (EXEL) Q3 2024 Earnings Call Transcript
Oct 30 EXEL Exelixis, Inc. 2024 Q3 - Results - Earnings Call Presentation
Oct 30 EXEL Exelixis, Inc. (EXEL) Q3 2024 Earnings Call Transcript
Oct 29 EXEL Exelixis (EXEL) Reports Q3 Earnings: What Key Metrics Have to Say
Receptor Tyrosine Kinase

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. Of the 90 unique tyrosine kinase genes identified in the human genome, 58 encode receptor tyrosine kinase proteins.
Receptor tyrosine kinases have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Mutations in receptor tyrosine kinases lead to activation of a series of signalling cascades which have numerous effects on protein expression. Receptor tyrosine kinases are part of the larger family of protein tyrosine kinases, encompassing the receptor tyrosine kinase proteins which contain a transmembrane domain, as well as the non-receptor tyrosine kinases which do not possess transmembrane domains.

Browse All Tags